• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Sherlock Biosciences

MedTech

CRISPR testmaker Sherlock Biosciences nabs Sense Biodetection

Sense acquired a CE Mark approval in Europe last year for its Veros test for COVID-19.
Conor Hale Feb 1, 2023 10:21am

Agios replaces CEO after recent FDA nod—Chutes & Ladders

Jul 15, 2022 9:30am

Sherlock Bio nets $80M to bring CRISPR-based tests into the home

Mar 8, 2022 12:56pm

Case closed: Sherlock Biosciences finds new CEO

Jul 12, 2021 10:05am

Sherlock Bio links with IDT to ship its CRISPR coronavirus test

Jun 8, 2020 10:35am

Sherlock's CRISPR-based coronavirus test gets emergency nod

May 7, 2020 9:00am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy